↓ Skip to main content

Dove Medical Press

Stem cell treatment for avascular necrosis of the femoral head: current perspectives

Overview of attention for article published in Stem cells and cloning advances and applications, April 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)

Mentioned by

news
2 news outlets
policy
1 policy source
twitter
11 X users
facebook
1 Facebook page

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
81 Mendeley
Title
Stem cell treatment for avascular necrosis of the femoral head: current perspectives
Published in
Stem cells and cloning advances and applications, April 2014
DOI 10.2147/sccaa.s36584
Pubmed ID
Authors

Matthew T Houdek, Cody C Wyles, John R Martin, Rafael J Sierra

Abstract

Avascular necrosis (AVN) of the femoral head is a progressive disease that predominantly affects younger patients. Although the exact pathophysiology of AVN has yet to be elucidated, the disease is characterized by a vascular insult to the blood supply of the femoral head, which can lead to collapse of the femoral head and subsequent degenerative changes. If AVN is diagnosed in the early stages of the disease, it may be possible to attempt surgical procedures which preserve the hip joint, including decompression of the femoral head augmented with concentrated bone marrow. The use of autologous stem cells has shown promise in halting the progression of AVN of the femoral head, and subsequently preventing young patients from undergoing total hip arthroplasty. The purpose of this study was to review the current use of stem cells for the treatment of AVN of the femoral head.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
United States 1 1%
Germany 1 1%
Unknown 78 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 15%
Researcher 12 15%
Other 11 14%
Student > Postgraduate 9 11%
Student > Ph. D. Student 7 9%
Other 11 14%
Unknown 19 23%
Readers by discipline Count As %
Medicine and Dentistry 39 48%
Agricultural and Biological Sciences 7 9%
Engineering 3 4%
Biochemistry, Genetics and Molecular Biology 2 2%
Nursing and Health Professions 1 1%
Other 6 7%
Unknown 23 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2023.
All research outputs
#1,333,270
of 25,584,565 outputs
Outputs from Stem cells and cloning advances and applications
#3
of 67 outputs
Outputs of similar age
#12,912
of 239,569 outputs
Outputs of similar age from Stem cells and cloning advances and applications
#1
of 2 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 67 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,569 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them